Clinical Trial Update: Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients. [NA]

View source ↗

Summary

A CHU Nice clinical trial is recruiting to evaluate anti-RACH antibodies and neurocognitive disorder in patients with Alzheimer's disease or myasthenia gravis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Myasthenia Gravis

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Alzheimer Disease, Myasthenia | NA | Status: RECRUITING